1.A Case of Glomus Tumor of the Stomach: Role of Endoscopic Ultrasonography.
Hyun Min SHIN ; Doo Yul RYU ; Ducky LEE ; Jong Hyung KIM ; Dong In HWANG ; Dong Joo LEE ; Seok En KIM ; Suk Joon PARK ; Sung Chul KIM
Korean Journal of Gastrointestinal Endoscopy 2000;21(5):855-858
A glomus tumor of the stomach is a rare submucosal lesion that was first described by De Busscher in 1948. Submucosal tumors of the stomach are mostly leiomyoma, leiomyosarcoma, and malignant lymphoma. It is difficult to diagnose this kind of tumor preoperatively. We present a patient with a gastric glomus tumor which showed the characteristic endoscopic ultrasonographic (EUS) finding. Our case was also diagnosed by pathology after surgery. The major EUS findings in the present case are circumscribed low echoic mass in the forth submucosal layer and an internal heterogenous echo mixed with high echoic spots. The EUS seems to be useful in distinguishing between glomus tumor and other submucosal tumors.
Endosonography*
;
Glomus Tumor*
;
Humans
;
Leiomyoma
;
Leiomyosarcoma
;
Lymphoma
;
Pathology
;
Stomach*
2.Efficacy and Safety of Radiofrequency Ablation for Benign Thyroid Nodules: A Prospective Multicenter Study
So Lyung JUNG ; Jung Hwan BAEK ; Jeong Hyun LEE ; Young Kee SHONG ; Jin Yong SUNG ; Kyu Sun KIM ; Ducky LEE ; Ji hoon KIM ; Seon Mi BAEK ; Jung Suk SIM ; Dong Gyu NA
Korean Journal of Radiology 2018;19(1):167-174
OBJECTIVE: To assess the efficacy and safety of thyroid radiofrequency (RF) ablation for benign thyroid nodules by trained radiologists according to a unified protocol in a multi-center study. MATERIALS AND METHODS: From 2010 to 2011, 345 nodules from 345 patients (M:F = 43:302; mean age ± SD = 46.0 ± 12.7 years, range = 15–79) who met eligibility criteria were enrolled from five institutions. At pre-ablation, the mean volume was 14.2 ± 13.2 mL (1.1–80.8 mL). For 12 months or longer after treatment, 276 lesions, consisting of 248 solid and 28 predominantly cystic nodules, were followed. All operators performed RF ablation with a cool-tip RF system and two standard techniques (a transisthmic approach and the moving-shot technique). Volume reduction at 12 months after RF ablation (the primary outcome), therapeutic success, improvement of symptoms as well as of cosmetic problems, and complications were evaluated. Multiple linear regression analysis was applied to identify factors that were independently predictive of volume reduction. RESULTS: The mean volume reduction at 12 months was 80.3% (n = 276) and at the 24-, 36-, 48-, and 60-month follow-ups 84.3% (n = 198), 89.2% (n = 128), 91.9% (n = 57), and 95.3% (n = 6), respectively. Our therapeutic success was 97.8%. Both mean symptom and cosmetic scores showed significant improvements (p < 0.001). The rate of major complications was 1.0% (3/276). Solidity and applied energy were independent factors that predicted volume reduction. CONCLUSION: Radiofrequency ablation performed by trained radiologists from multiple institutions using a unified protocol and similar devices was effective and safe for treating benign thyroid nodules.
Catheter Ablation
;
Follow-Up Studies
;
Humans
;
Linear Models
;
Prospective Studies
;
Thyroid Gland
;
Thyroid Nodule
;
Ultrasonography